Literature DB >> 12813013

C-reactive protein: a critical update.

Mark B Pepys1, Gideon M Hirschfield.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12813013      PMCID: PMC161431          DOI: 10.1172/JCI18921

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  58 in total

Review 1.  Regulation of complement activation by C-reactive protein.

Authors:  C Mold; H Gewurz; T W Du Clos
Journal:  Immunopharmacology       Date:  1999-05

2.  Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults.

Authors:  Earl S Ford
Journal:  Epidemiology       Date:  2002-09       Impact factor: 4.822

3.  Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

Authors:  P M Ridker; N Rifai; M Clearfield; J R Downs; S E Weis; J S Miles; A M Gotto
Journal:  N Engl J Med       Date:  2001-06-28       Impact factor: 91.245

4.  Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

Authors:  F Haverkate; S G Thompson; S D Pyke; J R Gallimore; M B Pepys
Journal:  Lancet       Date:  1997-02-15       Impact factor: 79.321

5.  C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis.

Authors:  T P Zwaka; V Hombach; J Torzewski
Journal:  Circulation       Date:  2001-03-06       Impact factor: 29.690

6.  Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis.

Authors:  M B Pepys; J Herbert; W L Hutchinson; G A Tennent; H J Lachmann; J R Gallimore; L B Lovat; T Bartfai; A Alanine; C Hertel; T Hoffmann; R Jakob-Roetne; R D Norcross; J A Kemp; K Yamamura; M Suzuki; G W Taylor; S Murray; D Thompson; A Purvis; S Kolstoe; S P Wood; P N Hawkins
Journal:  Nature       Date:  2002-05-16       Impact factor: 49.962

7.  C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids.

Authors:  Mi-Kyung Chang; Christoph J Binder; Michael Torzewski; Joseph L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-20       Impact factor: 11.205

8.  Phosphorylcholine: friend or foe of the immune system?

Authors:  W Harnett; M M Harnett
Journal:  Immunol Today       Date:  1999-03

9.  Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction.

Authors:  F C de Beer; C R Hind; K M Fox; R M Allan; A Maseri; M B Pepys
Journal:  Br Heart J       Date:  1982-03

10.  Studies of acute phase protein. I. An immunohistochemical method for the localization of Cx-reactive protein in rabbits. Association with necrosis in local inflammatory lesions.

Authors:  I KUSHNER; M H KAPLAN
Journal:  J Exp Med       Date:  1961-12-01       Impact factor: 14.307

View more
  1068 in total

1.  Antagonistic pleiotropy at the human IL6 promoter confers genetic resilience to the pro-inflammatory effects of adverse social conditions in adolescence.

Authors:  Steven W Cole; Jesusa M G Arevalo; Kavya Manu; Eva H Telzer; Lisa Kiang; Julienne E Bower; Michael R Irwin; Andrew J Fuligni
Journal:  Dev Psychol       Date:  2011-07

2.  Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease.

Authors:  Naim Alkhouri; Christine Carter-Kent; Michael Elias; Ariel E Feldstein
Journal:  Clin Lipidol       Date:  2011-06-01

3.  C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration.

Authors:  Imran A Bhutto; Takayuki Baba; Carol Merges; Vikash Juriasinghani; D Scott McLeod; Gerard A Lutty
Journal:  Br J Ophthalmol       Date:  2011-06-01       Impact factor: 4.638

4.  Association between high-sensitivity C-reactive protein and risk of early idiopathic Parkinson's disease.

Authors:  In-Uk Song; Sung-Woo Chung; Joong-Seok Kim; Kwang-Soo Lee
Journal:  Neurol Sci       Date:  2010-06-08       Impact factor: 3.307

5.  Endothelial injury markers before and after nasal continuous positive airway pressure treatment for obstructive sleep apnoea hypopnoea syndrome.

Authors:  Maria Wilczynska; Samuel Rice; Gareth Davies; Keir E Lewis
Journal:  Sleep Breath       Date:  2013-12-11       Impact factor: 2.816

6.  Crystallization and preliminary X-ray diffraction studies of choline-binding protein F from Streptococcus pneumoniae.

Authors:  Rafael Molina; Ana González; Miriam Moscoso; Pedro García; Meike Stelter; Richard Kahn; Juan A Hermoso
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-08-10

7.  C-reactive protein levels in hereditary angioedema.

Authors:  Z L M Hofman; A Relan; C E Hack
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

8.  Adverse mandibular bone effects associated with kidney disease are only partially corrected with bisphosphonate and/or calcium treatment.

Authors:  Matthew R Allen; Neal X Chen; Vincent H Gattone; Sharon M Moe
Journal:  Am J Nephrol       Date:  2013-11-22       Impact factor: 3.754

9.  Optimization of the secretory expression of recombinant human C-reactive protein in Pichia pastoris.

Authors:  Junming Li; Chengming Sun; Lei Chen; Lihui Sun; Lijun Duan; Qing Zheng; Xuejun Hu
Journal:  3 Biotech       Date:  2017-08-29       Impact factor: 2.406

10.  C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: a prospective cohort study.

Authors:  Kwok M Ho; Kok Y Lee; Geoffrey J Dobb; Steven A R Webb
Journal:  Intensive Care Med       Date:  2007-11-09       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.